Editor: Battling cancer has taught me that there are no guarantees in life. Anything can be taken away, and your perspective can change instantly. My journey to remission was not easy and there were many challenges during my recovery.
I know I would not be here today if it weren’t for our biopharmaceutical companies that continually develop innovative treatments. In America, we have access to the best medications available on the market and we are fortunate to have an industry dedicated to finding new cures.
Unfortunately, future therapies could be threatened if federal price-setting legislation like H.R.3 passes. These policies, while well intentioned, ultimately harm the patients who might need these treatments the most. Patients who suffer from cancer, diabetes, asthma, and other life-threatening illnesses might not have access to new cures, if research halts from bills like these.
I hope our representatives reject price-setting legislation and recognize the sever impact this could have on patients not only in Colorado, but across the country.
— Robert Golden, via [email protected]